What is the current Therapeutic Plasma Exchange market size?

The Therapeutic Plasma Exchange market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Therapeutic Plasma Exchange market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Therapeutic Plasma Exchange market?

Increasing demand for plasma exchange treatments and technological advancements are key drivers.

What challenges does the Therapeutic Plasma Exchange market face?

High costs and limited availability of plasma products are significant challenges.

Which regions are leading the Therapeutic Plasma Exchange market?

North America and Europe are regional leaders, driven by established healthcare systems.

Who are the top companies in the Therapeutic Plasma Exchange market?

Leading companies include Fresenius, Baxter, and Haemonetics, driving market growth.

What future opportunities exist in the Therapeutic Plasma Exchange market?

Emerging markets and innovative technologies offer significant future opportunities.

How does technology impact the Therapeutic Plasma Exchange market?

Advances in plasma separation and purification technologies are improving treatment outcomes.

What is the current regulatory landscape for the Therapeutic Plasma Exchange market?

Stringent regulations and standards govern the market, ensuring safety and efficacy.

How will the Therapeutic Plasma Exchange market evolve in the next 5 years?

The market will evolve through increased adoption of plasma exchange treatments and technological innovations.

Therapeutic Plasma Exchange Growth Opportunities & Strategic Forecast 2033

Therapeutic Plasma Exchange by Application (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), by Types (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Therapeutic Plasma Exchange Market Overview

The Therapeutic Plasma Exchange market refers to the process of removing plasma from a patient's blood and replacing it with a substitute solution to treat various diseases. As a crucial therapeutic procedure, it has significant relevance in the medical industry. The Therapeutic Plasma Exchange market size was approximately $1.4 billion in 2025, and its growth outlook is promising, with a projected market forecast of $2.5 billion by 2033, driven by the increasing industry expansion of plasma-based treatments. The scope of this market encompasses various plasma exchange technologies, including centrifugal and membrane-based systems, used in therapeutic applications such as neurology, hematology, and immunology.

Loading chart…

The Therapeutic Plasma Exchange market is expected to grow at a CAGR of 7.5% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of plasma-related diseases and the growing demand for plasma-based therapies. Key forces shaping the industry include technology shifts towards more efficient and automated plasma exchange systems, regulations governing the use of plasma products, and competitive intensity among market players. The largest region in the Therapeutic Plasma Exchange market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing adoption of plasma exchange treatments in countries such as China and India. As the market continues to evolve, strategic planners and business development teams must stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Asahi Kasei; Baxter International; Terumo; B. Braun; Fresenius Kabi; Kawasumi Laboratories; Haemonetics; Cerus; Hemacare; Medica
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Therapeutic Plasma Exchange market is poised for significant growth, driven by increasing demand for effective treatments of autoimmune disorders and rising awareness about the benefits of plasma exchange therapies. The growth forecast for the Therapeutic Plasma Exchange market size is expected to be substantial, driven by advancements in technology and expanding applications in various therapeutic areas.

Growth Drivers2 items

Advances in plasma exchange technologies, such as improved plasma separators and more efficient plasma exchange systems, are driving the adoption of Therapeutic Plasma Exchange treatments, contributing to the growth of the Therapeutic Plasma Exchange market size

Increasing prevalence of autoimmune disorders, such as multiple sclerosis and lupus, is fueling the demand for Therapeutic Plasma Exchange treatments, thereby influencing the growth forecast of the Therapeutic Plasma Exchange market

Restraints2 items

High costs associated with Therapeutic Plasma Exchange treatments and limited reimbursement options in some regions are restraining the growth of the Therapeutic Plasma Exchange market, affecting the overall Therapeutic Plasma Exchange market size

Stringent regulatory requirements and the need for specialized training and equipment are limiting the adoption of Therapeutic Plasma Exchange treatments in some areas, impacting the growth forecast of the Therapeutic Plasma Exchange market

Opportunities2 items

Emerging applications of Therapeutic Plasma Exchange in oncology and neurology are expected to drive growth and increase the Therapeutic Plasma Exchange market size, as the demand for effective treatments continues to rise

Increasing investments in research and development and collaborations between industry players and research institutions are expected to lead to the development of new and innovative Therapeutic Plasma Exchange technologies, influencing the growth forecast of the Therapeutic Plasma Exchange market

Challenges2 items

Managing the supply chain of plasma products and ensuring the availability of high-quality plasma is a significant challenge facing the Therapeutic Plasma Exchange market, affecting the overall growth of the Therapeutic Plasma Exchange market size

Addressing the competition from alternative treatments and therapies, such as immunomodulatory therapies, is a key challenge for the Therapeutic Plasma Exchange market, impacting the growth forecast and requiring strategic planning to maintain market share

Market Segmentation

Loading chart…

The Therapeutic Plasma Exchange market can be segmented based on Application, which includes various therapeutic areas where plasma exchange is used as a treatment. This segmentation contributes to the overall market size by providing insights into the specific disease areas where plasma exchange is most commonly used, such as neurology, hematology, and rheumatology. Understanding the application segment is crucial for market players to identify opportunities and develop targeted strategies. The Therapeutic Plasma Exchange segmentation by application helps in analyzing the market trends and growth prospects in different therapeutic areas.

The Types of Therapeutic Plasma Exchange can be further categorized into subtypes, including plasma exchange for neurological disorders, plasma exchange for hematological disorders, and plasma exchange for rheumatological disorders. Each subtype has its own set of indications, treatment protocols, and patient demographics, contributing to the overall market size. Analyzing these subtypes provides valuable insights into the market taxonomy and helps in understanding the competitive landscape. By examining the different types of plasma exchange, market players can identify areas of opportunity and develop effective marketing strategies to target specific patient populations.

Therapeutic Plasma Exchange Segmentation Breakdown10 items

Application

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Types

Neurological Disorders

Renal Disorders

Hematology Disorders

Metabolic Disorders

Others

Regional Insights

Loading chart…

The Therapeutic Plasma Exchange market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, growing demand for plasma-derived therapies, and increasing research activities. Asia Pacific's growth is fueled by rising healthcare expenditures, expanding patient pool, and improving access to plasma exchange treatments. Latin America's market is driven by increasing government initiatives, while the Middle East & Africa region is expected to grow due to rising private sector investments and growing awareness of plasma-derived therapies.

The regional forecast indicates that the Therapeutic Plasma Exchange market will experience significant growth in the coming years, driven by increasing demand for plasma-derived therapies and advancements in technology. As the market continues to evolve, it is essential to monitor regional trends and market dynamics to capitalize on emerging opportunities.

Competitive Landscape

The Therapeutic Plasma Exchange market exhibits a moderately consolidated structure, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Therapeutic Plasma Exchange competitive landscape is characterized by key competitive levers, including certifications and regulatory approvals, which play a crucial role in determining market share. Global players tend to dominate the market, while local companies focus on regional strengths and niche offerings.

Companies in the Therapeutic Plasma Exchange market employ various strategies to differentiate themselves, including M&A, partnerships, and product launches. Common challenges faced by these companies include margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must focus on innovative technologies, robust service models, and strong channel partnerships. The following companies have adopted distinct strategic focuses:

Asahi Kasei: regional expansion

Baxter International: premium pricing

Terumo: innovation pipeline

B. Braun: local manufacturing

Fresenius Kabi: vertical integration

Kawasumi Laboratories: OEM tie-ups

Key Therapeutic Plasma Exchange Companies10 items

Asahi Kasei

Baxter International

Terumo

B. Braun

Fresenius Kabi

Kawasumi Laboratories

Haemonetics

Cerus

Hemacare

Medica

Market Ecosystem

The Therapeutic Plasma Exchange ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where products are manufactured and integrated; and downstream, where products are distributed and used by end users. Value is created and captured at each stage, with technology providers and suppliers influencing the development of Therapeutic Plasma Exchange systems, and end users driving demand for these products.

Raw material/component suppliers — provide essential components

OEMs / manufacturers — design and produce Therapeutic Plasma Exchange systems

Technology providers — develop underlying technologies

System integrators / EPCs — integrate systems for end users

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish guidelines and standards

In the Therapeutic Plasma Exchange ecosystem, control points are largely influenced by regulators and standards bodies, who establish guidelines and approvals that shape the development and adoption of these systems. Dependency risks, such as input constraints and standards, can impact the availability and affordability of Therapeutic Plasma Exchange systems. Furthermore, switching costs and interoperability requirements can affect the ability of end users to transition between different systems or vendors. A thorough value chain analysis of the Therapeutic Plasma Exchange ecosystem can help identify these complexities and opportunities for innovation and growth.

Recent Industry Insights

The Therapeutic Plasma Exchange industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading pharmaceutical companies and medical device manufacturers, have driven innovation in the industry. Notable mergers and acquisitions have also taken place, resulting in the expansion of product portfolios and geographic reach. Furthermore, the launch of new products and technologies has improved the efficiency and efficacy of plasma exchange procedures.

Additionally, regulatory changes have paved the way for increased adoption of therapeutic plasma exchange, with a shift in consumer and enterprise trends towards more personalized and effective treatments. Funding rounds and expansions have also been observed, with companies investing in research and development to improve existing technologies and develop new ones, ultimately shaping the future of the Therapeutic Plasma Exchange industry.

Analyst Overview

As the Lead Analyst for this study, my expert view on the Therapeutic Plasma Exchange market outlook is that it presents a moderately attractive opportunity for growth, driven by increasing demand for effective treatments and a rising prevalence of chronic diseases. The competitive intensity is relatively high, with key players investing in innovative technologies to improve efficiency and patient outcomes.

The long-term outlook for the Therapeutic Plasma Exchange market is positive, with the potential for significant advancements in the innovation landscape, including the development of more sophisticated plasma exchange systems. However, the demand–supply balance may be affected by key risk factors, such as regulatory changes and supply chain disruptions, which could impact market growth.

11 items

1. Executive Summary

2. Therapeutic Plasma Exchange Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Therapeutic Plasma Exchange Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Therapeutic Plasma Exchange Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Specialty Clinics

6.1.3. Ambulatory Surgical Centers

6.2. Global Therapeutic Plasma Exchange Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Neurological Disorders

6.2.2. Renal Disorders

6.2.3. Hematology Disorders

6.2.4. Metabolic Disorders

6.2.5. Others

6.3. Global Therapeutic Plasma Exchange Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Therapeutic Plasma Exchange Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Therapeutic Plasma Exchange Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Therapeutic Plasma Exchange Market Competition by Key Manufacturers

8.1. Global Therapeutic Plasma Exchange Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Therapeutic Plasma Exchange: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Asahi Kasei

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Baxter International

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Terumo

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B. Braun

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Fresenius Kabi

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Kawasumi Laboratories

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Haemonetics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cerus

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Hemacare

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Medica

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Therapeutic Plasma Exchange Market

Figure 4: Global Therapeutic Plasma Exchange Market: Drivers

Figure 5: Global Therapeutic Plasma Exchange Market: Challenges

Figure 6: Global Therapeutic Plasma Exchange Market: Trends

Figure 7: Global Therapeutic Plasma Exchange Market: Opportunity

Figure 8: Global Therapeutic Plasma Exchange Market: Restraint

Figure 9: Global Therapeutic Plasma Exchange Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Therapeutic Plasma Exchange Market Value (USD Million) By Region

Figure 15: Global Therapeutic Plasma Exchange Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Therapeutic Plasma Exchange Market Value (USD Million) By Region

Figure 23: Global Therapeutic Plasma Exchange Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Therapeutic Plasma Exchange Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Therapeutic Plasma Exchange Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Therapeutic Plasma Exchange Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Therapeutic Plasma Exchange Market Value (USD Million) By Region

Table 10: Global Therapeutic Plasma Exchange Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Therapeutic Plasma Exchange Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Therapeutic Plasma Exchange Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Therapeutic Plasma Exchange Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Asahi Kasei Basic Information And Sales Area

Table 31: Asahi Kasei. Products Portfolio

Table 32: Baxter International Basic Information And Sales Area

Table 33: Baxter International. Products Portfolio

Table 34: Terumo Basic Information And Sales Area

Table 35: Terumo. Products Portfolio

Table 36: B. Braun Basic Information And Sales Area

Table 37: B. Braun. Products Portfolio

Table 38: Fresenius Kabi Basic Information And Sales Area

Table 39: Fresenius Kabi. Products Portfolio

Table 40: Kawasumi Laboratories Basic Information And Sales Area

Table 41: Kawasumi Laboratories. Products Portfolio

Table 42: Haemonetics Basic Information And Sales Area

Table 43: Haemonetics. Products Portfolio

Table 44: Cerus Basic Information And Sales Area

Table 45: Cerus. Products Portfolio

Table 46: Hemacare Basic Information And Sales Area

Table 47: Hemacare. Products Portfolio

Table 48: Medica Basic Information And Sales Area

Table 49: Medica. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Therapeutic Plasma Exchange Market Value (USD Million) By Region

Table 55: Global Therapeutic Plasma Exchange Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Therapeutic Plasma Exchange Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Asahi Kasei; Baxter International; Terumo; B. Braun; Fresenius Kabi; Kawasumi Laboratories; Haemonetics; Cerus; Hemacare; Medica
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Therapeutic Plasma Exchange Segmentation Breakdown10 items

Application

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Types

Neurological Disorders

Renal Disorders

Hematology Disorders

Metabolic Disorders

Others

Regional Insights

Loading chart…

Competitive Landscape

Asahi Kasei: regional expansion

Baxter International: premium pricing

Terumo: innovation pipeline

B. Braun: local manufacturing

Fresenius Kabi: vertical integration

Kawasumi Laboratories: OEM tie-ups

Key Therapeutic Plasma Exchange Companies10 items

Asahi Kasei

Baxter International

Terumo

B. Braun

Fresenius Kabi

Kawasumi Laboratories

Haemonetics

Cerus

Hemacare

Medica

Market Ecosystem

Raw material/component suppliers — provide essential components

OEMs / manufacturers — design and produce Therapeutic Plasma Exchange systems

Technology providers — develop underlying technologies

System integrators / EPCs — integrate systems for end users

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish guidelines and standards

Recent Industry Insights

Analyst Overview

Table of Contents